JP2008518953A - 連鎖球菌修飾多糖類およびそれらの使用法 - Google Patents

連鎖球菌修飾多糖類およびそれらの使用法 Download PDF

Info

Publication number
JP2008518953A
JP2008518953A JP2007539289A JP2007539289A JP2008518953A JP 2008518953 A JP2008518953 A JP 2008518953A JP 2007539289 A JP2007539289 A JP 2007539289A JP 2007539289 A JP2007539289 A JP 2007539289A JP 2008518953 A JP2008518953 A JP 2008518953A
Authority
JP
Japan
Prior art keywords
polysaccharide
gbs
type
composition
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007539289A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008518953A5 (cg-RX-API-DMAC7.html
Inventor
エル キャスパー,デニス
グットルムセン,ヒルデ−カリ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The Brigham and Women's Hospital Inc
Original Assignee
The Brigham and Women's Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Brigham and Women's Hospital Inc filed Critical The Brigham and Women's Hospital Inc
Publication of JP2008518953A publication Critical patent/JP2008518953A/ja
Publication of JP2008518953A5 publication Critical patent/JP2008518953A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP2007539289A 2004-11-01 2005-11-01 連鎖球菌修飾多糖類およびそれらの使用法 Pending JP2008518953A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62390704P 2004-11-01 2004-11-01
PCT/US2005/039424 WO2006050341A2 (en) 2004-11-01 2005-11-01 Modified streptococcal polysaccharides and uses thereof

Publications (2)

Publication Number Publication Date
JP2008518953A true JP2008518953A (ja) 2008-06-05
JP2008518953A5 JP2008518953A5 (cg-RX-API-DMAC7.html) 2008-12-25

Family

ID=36319754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007539289A Pending JP2008518953A (ja) 2004-11-01 2005-11-01 連鎖球菌修飾多糖類およびそれらの使用法

Country Status (8)

Country Link
US (1) US7858101B2 (cg-RX-API-DMAC7.html)
EP (1) EP1812057A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008518953A (cg-RX-API-DMAC7.html)
CN (1) CN101107010A (cg-RX-API-DMAC7.html)
AU (1) AU2005302269B2 (cg-RX-API-DMAC7.html)
CA (1) CA2586058A1 (cg-RX-API-DMAC7.html)
MX (1) MX2007005202A (cg-RX-API-DMAC7.html)
WO (1) WO2006050341A2 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0502095D0 (en) * 2005-02-01 2005-03-09 Chiron Srl Conjugation of streptococcal capsular saccharides
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
GB0713880D0 (en) 2007-07-17 2007-08-29 Novartis Ag Conjugate purification
GB201003333D0 (en) 2010-02-26 2010-04-14 Novartis Ag Immunogenic proteins and compositions
GB201005625D0 (en) 2010-04-01 2010-05-19 Novartis Ag Immunogenic proteins and compositions
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
CN103764171B (zh) 2011-07-08 2016-08-17 诺华股份有限公司 酪氨酸连接方法
GB201114923D0 (en) 2011-08-30 2011-10-12 Novartis Ag Immunogenic proteins and compositions
RU2636350C2 (ru) 2011-11-07 2017-11-22 Новартис Аг МОЛЕКУЛА, СОДЕРЖАЩАЯ SPR0096 и SPR2021
CN104582718B (zh) 2012-10-03 2017-10-24 诺华股份有限公司 免疫原性组合物
GB201300707D0 (en) 2013-01-15 2013-02-27 Novartis Ag Compounds and processes
KR20160040556A (ko) 2013-07-11 2016-04-14 노파르티스 아게 미생물 트랜스글루타미나제를 사용한 리신-특이적 화학효소적 단백질 변형
US10751402B2 (en) 2016-11-09 2020-08-25 Pfizer Inc. Immunogenic compositions and uses thereof
EP3638301A1 (en) 2017-06-16 2020-04-22 GlaxoSmithKline Biologicals S.A. Method of treatment
CA3139257A1 (en) 2019-05-10 2020-11-19 Glaxosmithkline Biologicals Sa Conjugate production
BR112022008761A2 (pt) 2019-11-22 2022-07-26 Glaxosmithkline Biologicals Sa Dosagem e administração de uma vacina de glicoconjugado de sacarídeo
US20230250142A1 (en) 2020-06-12 2023-08-10 Glaxosmithkline Biologicals Sa Dock tag system

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08501563A (ja) * 1992-09-24 1996-02-20 ブリガーム アンド ウーメンズ ホスピタル インコーポレイテッド グループbストレプトコッカス・タイプ▲ii▼およびタイプ▲v▼多糖−蛋白質接合ワクチン
WO2004011027A1 (en) * 2002-07-30 2004-02-05 Baxter International Inc. Chimeric multivalent polysaccharide conjugate vaccines

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324887A (en) 1978-08-16 1982-04-13 President And Fellows Of Harvard College Type II group B Streptococci polysaccharide
US4207414A (en) 1978-08-16 1980-06-10 President And Fellows Of Harvard College Polysaccharide antigens
US4438261A (en) 1980-05-19 1984-03-20 Riker Laboratories, Inc. Anticoagulant substance
US4367222A (en) 1980-06-09 1983-01-04 President And Fellows Of Harvard College Immune globulin specific to Group B streptococci
US4356263A (en) 1980-06-09 1982-10-26 President And Fellows Of Harvard College Method of making a polysaccharide vaccine
US4367221A (en) 1980-06-09 1983-01-04 President And Fellows Of Harvard College Immunization against Group B streptococci
US4367223A (en) 1980-06-09 1983-01-04 President And Fellows Of Harvard College Vaccine against Group B streptococci
US4284537A (en) 1980-07-03 1981-08-18 The United States Of America As Represented By The Department Of Health And Human Services Conjugate of streptococcal M protein peptide vaccine
US4425330A (en) 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4902506A (en) 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4619828A (en) 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4757134A (en) 1982-12-02 1988-07-12 The Rockefeller University IgA binding protein
FR2581877B1 (fr) 1985-05-14 1987-12-18 Louvain Universite Catholique Conjugue constitue d'une adhesine de paroi de s. mutans, de nature proteique et d'un polysaccharide de s. mutans, sa preparation et son utilisation notamment dans des vaccins anti-caries
US5302386A (en) 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5472696A (en) * 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5648241A (en) 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
ZA937034B (en) 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
US6355255B1 (en) * 1998-12-07 2002-03-12 Regents Of The University Of Minnesota Streptococcal C5a peptidase vaccine
AU2001281168A1 (en) 2000-08-08 2002-02-18 St. Jude Children's Research Hospital Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08501563A (ja) * 1992-09-24 1996-02-20 ブリガーム アンド ウーメンズ ホスピタル インコーポレイテッド グループbストレプトコッカス・タイプ▲ii▼およびタイプ▲v▼多糖−蛋白質接合ワクチン
US5795580A (en) * 1992-09-24 1998-08-18 National Research Council Of Canada Group B streptococcus type V polysaccharide-protein conjugate vaccines
WO2004011027A1 (en) * 2002-07-30 2004-02-05 Baxter International Inc. Chimeric multivalent polysaccharide conjugate vaccines

Also Published As

Publication number Publication date
EP1812057A2 (en) 2007-08-01
EP1812057A4 (en) 2009-07-22
US20060134142A1 (en) 2006-06-22
CN101107010A (zh) 2008-01-16
WO2006050341A2 (en) 2006-05-11
AU2005302269A1 (en) 2006-05-11
MX2007005202A (es) 2007-07-09
CA2586058A1 (en) 2006-05-11
WO2006050341A3 (en) 2006-06-15
US7858101B2 (en) 2010-12-28
AU2005302269B2 (en) 2011-05-19

Similar Documents

Publication Publication Date Title
AU2023201579B2 (en) Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
JP2024112952A (ja) 肺炎連鎖球菌多糖-タンパク質コンジュゲートの免疫原性の増強
RU2493870C2 (ru) Мультивалентная композиция на основе конъюгата пневмокковый полисахарид-белок
TWI684461B (zh) 包含經共軛之莢膜糖抗原的致免疫性組成物、包含該致免疫性組成物之套組及彼等之用途
KR101511393B1 (ko) 다가 폐렴구균 다당류-단백질 접합체 조성물
EP2170391B1 (en) Modified polysaccharides for conjugate vaccines
US20040096461A1 (en) Chimeric multivalent polysaccharide conjugate vaccines
US7858101B2 (en) Modified streptococcal polysaccharides and uses thereof
KR20190055063A (ko) 다가 폐렴구균 다당류-단백질 접합체 조성물
EA023059B1 (ru) Способ конъюгирования бактериальных полисахаридов с белками-носителями
KR20190051945A (ko) 다가 폐렴구균 다당류-단백질 접합체 조성물
US20140378669A1 (en) Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid
US20180271969A1 (en) Streptococcus suis polysaccharide-protein conjugate composition
MXPA05014015A (es) Vacunas contra grupo y nisseria meningitidis y combinaciones meningococales del mismo.
Wu et al. Investigation of nontypeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines
US7527949B2 (en) Polysaccharides of Helicobacter pylori
RU2818894C1 (ru) Свободные от примеси с-полисахарида капсульные полисахариды streptococcus pneumoniae с остатком 2,5-ангидроманнозы на восстанавливающем конце
HK40042634A (en) Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
HK1142261A (en) Modified polysaccharides for conjugate vaccines

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081104

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20081104

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110628

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111122